XShares Advisors LLC, an industry leader in developing innovative
exchange traded products, today announced the distribution declarations
for its HealthShares Exchange-Traded Funds (ETFs) (the "Funds"). For all
dividend payments, the ex-dividend payment date is December 19, 2008,
payable December 31, to holders of record on December 23. The following
table includes a list of the distributions:
|
FUND NAME
|
Ticker Symbol
|
|
Net Investment Income
|
|
Short-term Capital Gains
|
|
Long-term Capital Gains
|
|
Total Distribution
|
|
HealthShares™ Diagnostics Exchange-Traded Fund
|
HHD
|
|
$0.00
|
|
$0.00
|
|
$0.00
|
|
$0.00
|
|
HealthShares™ Cancer Exchange-Traded Fund
|
HHK
|
|
$0.733357
|
|
$0.507388
|
|
$0.433731
|
|
$1.674476
|
|
HealthShares™ European Drugs Exchange-Traded Fund
|
HRJ
|
|
$0.00
|
|
$0.00
|
|
$0.00
|
|
$0.00
|
|
HealthShares™ Drug Discovery Tools Exchange-Traded Fund (formerly
HealthShares™ Enabling Technologies Fund)
|
HHV
|
|
$0.00
|
|
$0.00
|
|
$0.00
|
|
$0.00
|
As announced on November 26, 2008, the last day of trading on NYSE Arca
for [units of beneficial interest] in the Funds ("Shares") and the last
day on which creation unit aggregations of the Shares may be purchased
or redeemed of the Funds was December 23, 2008.
NYSE Arca will halt trading in the Shares of the Funds before the open
of trading on December 24, 2008, and the Funds will be closed to new
investment on that date. Shareholders may sell their Shares on or prior
to December 23, 2008. From December 24, 2008 through December 31, 2008,
shareholders may be able to sell their Shares to certain broker-dealers
who may determine to continue to purchase such Shares, but there can be
no assurance that any broker-dealer will be willing to purchase such
Shares or that there will be a market for the Shares of the Funds. All
sales of Shares to a broker-dealer, whether before or after December 23,
2008, will be subject to typical transaction fees and charges. All
shareholders remaining on December 31, 2008 will receive cash equal to
the amount of the net asset value of their Shares as of December 31,
2008, which will include any capital gains and dividends, into the cash
portion of their brokerage accounts. Fund shareholders remaining on
December 31, 2008 will not incur transaction fees to sell their Shares.
Other costs of closing the Funds will be borne by XShares.
For additional information about the liquidation, shareholders of the
Funds may call XShares at 1-800-925-2870.
Before investing in an ETF, carefully consider the investment
objectives, risks, charges and expenses. For a prospectus containing
this and other important information, contact a Client Services
representative at 800-669-3900. The prospectus should be read carefully
before investing.
About XShares Advisors LLC
XShares Advisors LLC, a registered investment advisor, sponsors and
develops innovative exchange traded products (ETPs). XShares Advisors
partners with major institutions and index providers to create and
license distinctive intellectual property for its ETPs. For more
information, visit the company’s website at: www.xsharesadvisors.com.
ETFs are subject to risk similar to those of stocks including those
regarding short-selling and margin account maintenance. ETFs may entail
market, sector, and industry risks similar to direct stock ownership,
and trading prices may not reflect the actual net asset value of the
underlying securities.
HealthShares ETFs face additional risks attributable to their
investments in small- and medium-capitalization companies which are
subject to higher volatility than larger, more established companies. In
addition, they are invested in a limited number of securities and a
decline in the value of these investments would cause the fund’s overall
value to decline to a greater degree than in a less concentrated
portfolio. HealthShares are subject to additional risks associated with
the healthcare and biotechnology sector (i.e., government regulation,
patent regulation, etc.). Certain HealthShares ETFs invest in foreign
securities that will be subject to certain risks not associated with
domestic securities, such as currency fluctuations and changes in
political and economic conditions.
XShares Advisors LLC and ALPS Distributors, Inc. are unaffiliated
entities.
Distributed by ALPS Distributors, Inc.
HSI 585 Exp. 5/31/09
Makovsky + Co.
John McInerney, 212-580-9628
jmcinerney@makovsky.com